Stocks/FOXA

FOXA three-lens brief

Evidence-based stock research on FOXA. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of Jul 10
$48.34$54.82$76.39

Performance

1W
-2.9%
1M
-19.8%
3M
-10.2%
6M
-25.6%
YTD
-25.0%
1Y
-3.4%
3Y
5Y
FOXA · Nightly brief
Inspect

Moved +2.01% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.

  • Moved +2.01% yesterday.
  • 50-day MA below 200-day MA (death-cross regime); price below both.
  • Underperforming SPY by 16.7pp over 30 days.
  • Analyst mean target $70.80 — 29% above current (17 analysts).
  • 8-K filing filed 2026-06-30.

FOXA closed at $54.82 (+2.01%) as of 2026-07-10. Market cap: $23.02B. P/E (trailing) 14.4. Price is below the 50-day MA and below the 200-day MA. Positives: moved +2.01% yesterday.; analyst mean target $70.80 — 29% above current (17 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; underperforming SPY by 16.7pp over 30 days.. Last quarter: Revenue $3.99B, net income $166.00M, free cash flow $1.41B. Watching for: 2026-08-05 earnings release (25 days out).

Market ✓· Fundamentals ✓· 2 events
Informational only · Not investment advice
Three-lens method

Why three lenses on FOXA, not one.

A single reasoning model has blind spots it doesn’t know about. We examine FOXAacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/FOXA"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath FOXA brief"></iframe>